Aarti Drugs Balance Sheet Health
Financial Health criteria checks 5/6
Aarti Drugs has a total shareholder equity of ₹12.1B and total debt of ₹5.9B, which brings its debt-to-equity ratio to 48.7%. Its total assets and total liabilities are ₹23.5B and ₹11.4B respectively. Aarti Drugs's EBIT is ₹2.8B making its interest coverage ratio 8.6. It has cash and short-term investments of ₹249.9M.
Key information
48.7%
Debt to equity ratio
₹5.89b
Debt
Interest coverage ratio | 8.6x |
Cash | ₹249.90m |
Equity | ₹12.10b |
Total liabilities | ₹11.42b |
Total assets | ₹23.52b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524348's short term assets (₹13.4B) exceed its short term liabilities (₹8.3B).
Long Term Liabilities: 524348's short term assets (₹13.4B) exceed its long term liabilities (₹3.1B).
Debt to Equity History and Analysis
Debt Level: 524348's net debt to equity ratio (46.6%) is considered high.
Reducing Debt: 524348's debt to equity ratio has reduced from 104.8% to 48.7% over the past 5 years.
Debt Coverage: 524348's debt is well covered by operating cash flow (53.8%).
Interest Coverage: 524348's interest payments on its debt are well covered by EBIT (8.6x coverage).